课题基金 / 基金详情

Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells

Role of CD109 in regulating cellular signaling and responses in skin and oral squamous cell carcinoma cells
CD109 在调节皮肤和口腔鳞状细胞癌细胞的细胞信号传导和反应中的作用
批准号：
391152
负责人：
Philip Anie
金额：
$78.3万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-09-01 至 2023-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=391152&lang=en
关键词：
Cd109 Cell Signaling Epidermal Growth Factor Jak/Stat3 Metastasis Squamous Cell Carcinoma Tgf-Beta

项目摘要

项目成果

Philip Anie的其他基金

相似基金

相关文献

中文摘要
翻译
鳞状细胞癌（SCC）是最常见的恶性肿瘤类型之一，其发病率在全球范围内持续增加。癌症的致命后果是由于癌细胞从原来的肿瘤部位扩散（转移）到其他部位。
英文摘要
Squamous cell carcinoma (SCC) is one of the most prevalent types of malignancy and its incidence continues to increase globally. The fatal consequences of cancer are due to the spreading (metastasis) of cancer cells from the original tumor site to other o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of a novel anti-fibrotic peptide for the treatment of scleroderma
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
Regulation of TGF-beta action in chondrocytes: signaling via ALK1 versus ALK5 pathways
Skin Repair, Regeneration and Restoration Research Group (SR4G)
海外基金